The Arkansas Supreme Court on Thursday declined to reconsider its decision that threw out a $1.2...
Eli Lilly's first-quarter earnings plunged 53 percent after the expiration of a key patent...
Strong new drug sales helped Novartis AG report a 24 percent rise in first-quarter profit. The...
Health officials are worried about recent U.S. measles outbreaks that so far have caused more illnesses than at the same point of any year since 1996. Authorities say 129 cases in 13 states were reported by mid-April, the bulk of them in California and New York City.
AmerisourceBergen's profit surged and revenue soared during the second, thanks largely to a supply deal the prescription drug distributor signed with Walgreen last year. It also raised its profit expectations for the year.
The Manesty TPR 500 tablet press is equipped with several technical novelties such as a die table, torque drive and tablet discharge chute, as well as an intuitive human machine interface (HMI).
The recent flurry of drug deals shows how the global pharmaceutical industry is reversing course, as companies narrow their focus after decades of diversifying their drug portfolios.
Report takes a look at new treatments that may help prevent migraines.
Working platforms can be installed inside almost all conical process vessels like reactors, Nauta style mixer/dryers and single shaft dryers and mixers.
The World Health Organization says 147 people have died from the Ebola virus outbreak in West Africa. In a statement posted on its website, the organization said more than 240 cases of the virus have been recorded in Guinea and Liberia.
The FDA has approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes an abnormal overgrowth of immune cells in lymph nodes and related tissues in the body.
Celgene Corporation entered into a global license agreement with Nogra Pharma Limited, a private pharmaceutical company based in Dublin, Ireland, to develop and commercialize GED-0301, an oral antisense DNA oligonucleotide targeting Smad7 mRNA for the treatment of moderate-to-severe Crohn’s disease and other indications.
Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes.
The federal government wants to ban sales of electronic cigarettes to minors and require approval for new products and health warning labels under regulations being proposed by the Food and Drug Administration.
Valeant Pharmaceuticals International says three of its directors will not stand for re-election this year as it pursues the acquisition of Botox maker Allergan, which has adopted a "poison pill" defense while it considers the offer.
EMD Millipore has announced the appointment of Udit Batra, Ph.D. as its incoming President and CEO, responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations. Dr. Batra will assume leadership effective May 15, 2014 and be based at the company’s U.S. headquarters in Massachusetts.
A Kemper County drugmaker has laid off most of its remaining employees, making it likely that it will shut down while owing the state economic development money. Pharma Pac laid off 84 employees from its DeKalb facility on March 7, according to a notice filed with the Mississippi Department of Employment Security.
Zogenix has released a statement regarding Massachusetts’s restriction of Zohydro.